Figure 3
Figure 3. Detection of β2GPI with antibodies. (A) ELISA plates were coated with purified anti-β2GPI IgGs isolated from APS patients. Circular or open β2GPI was added, and binding of β2GPI was measured with a polyclonal anti–β2GPI antibody labeled with horseradish peroxidase. (▬) Open conformation of β2GPI. () Circular conformation of β2GPI. As a control for β2GPI concentration, a mouse monoclonal anti–domain IV of β2GPI antibody was used. Bars represent mean ± SD (n = 3). (B) ELISA plates were coated with cardiolipin, and a serial dilution (0.4-50 μg/mL) of circular (●) or open (▴) β2GPI was added, subsequently followed by addition of purified APS patient IgG antibodies. Binding of β2GPI was measured with a goat anti-IgG alkaline phosphatase–conjugated antibody.

Detection of β2GPI with antibodies. (A) ELISA plates were coated with purified anti-β2GPI IgGs isolated from APS patients. Circular or open β2GPI was added, and binding of β2GPI was measured with a polyclonal anti–β2GPI antibody labeled with horseradish peroxidase. (▬) Open conformation of β2GPI. () Circular conformation of β2GPI. As a control for β2GPI concentration, a mouse monoclonal anti–domain IV of β2GPI antibody was used. Bars represent mean ± SD (n = 3). (B) ELISA plates were coated with cardiolipin, and a serial dilution (0.4-50 μg/mL) of circular (●) or open (▴) β2GPI was added, subsequently followed by addition of purified APS patient IgG antibodies. Binding of β2GPI was measured with a goat anti-IgG alkaline phosphatase–conjugated antibody.

Close Modal

or Create an Account

Close Modal
Close Modal